לבטיראצטם דקסל 500

Land: Israël

Taal: Hebreeuws

Bron: Ministry of Health

Werkstoffen:

LEVETIRACETAM

Beschikbaar vanaf:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC-code:

N03AX14

farmaceutische vorm:

טבליה

Samenstelling:

LEVETIRACETAM 500 MG

Toedieningsweg:

פומי

Prescription-type:

מרשם נדרש

Geproduceerd door:

DEXCEL LTD, ISRAEL

Therapeutische categorie:

LEVETIRACETAM

Therapeutisch gebied:

LEVETIRACETAM

therapeutische indicaties:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Product samenvatting:

א. התרופה האמורה תינתן לטיפול באפילפסיה. ב. מתן התרופה ייעשה לפי המלצת רופא מומחה בנוירולוגיה.

Autorisatie datum:

2018-03-31

Bijsluiter

(
)
"
-
1986
250
,
500 ,
750 ,
1000
,
(
Levetiracetam
)
250
,
500
,
750
1000
"
,
.
-
6
"
"
2
"
"
.
.
.
,
.
.
.
.
1
.
?

16
.

-
:

4
,
.

12
Juvenile myoclonic epilepsy
Idiopathic generalised epilepsy
.
:
.
2
.
:

)
(
(
)
(Pyrrolidone)
(
6
.)
: ,

.
.

,
.

/
.
-
.
.
.
:
,
,
,
,
.

) "
(
.

:
o
,
,
.
o
:
,
,
.
.
,
)
(
(
SCN8A
)
.
, - !
16
.
,
, , .
:

)
(
.
,
.

.
.
,
.
.)
(
.
,
.
.
,
,
,
.
,
.
.
.
.
,
.
.
.
,
.
-
1
(
23
) "
,
."
"
750
Sunset yellow (E110)
,
.
3
.
?
.
.
. .
)
(
.
-
2
.
.
,
.
.
.

.
.

.
,
.
:
,
,
,
,
.
,
.
.
.
,
.
,
.
! . . ,
.
4
.
,
.
.
.
:

,
.
)
(
.

,
,
(
s oedema
’
Quincke
)
.

,
(
)
(
DRESS
)
.

,
,
,
,
,
.
.

(
,
)
(
)
.

,
,
,
(
-
)
'
.

-
30%
(
)
.

,
,
(
)
,)
(
,
.
.
,
,
,
.
,
,
.
.
(
)
:


,
(
1-10
100
)
:

(
)

,
,
,
,

,
,
,
(
-
)
,

)
(


,
,
,
,


(
1-10
1,000
)
:

,


,
,
,
,
,
,
,
,
(
)

,
,)
(
/
(
)
,
)
(
,

,

/

,
,

,

(
1-10
10,000
:)



(
DRESS
,
[
,]
Quincke
’
s oedema
[
,
,
)]


,
,
(
,
)


)
"
"
(


,
)
(
,
,
(
)

) "
(

(
)

,
(
)


(
,
)
)
(
,
,
,
,
(
-
)
'
,
-
30%
(
)

(
)
.


(
,
,
,
,
.)
.
(
10,000
:)

.)
( ,
. ,
"
"
(
www.health.gov.il
)
,
:
https://sideeffects.health.gov.il
5
.
?

!
/
.
.

.
.

:
-
25°C
.
6
.
,
:
Croscarmellose sodium, microcrystalline cellulose, povidone, glyceryl
behenate, polyvinyl
alcohol partially hydrolyzed, titanium dioxide (E171), macrogol 3350,
talc, silica colloidal
anhydrous, carnauba wax.
250
Indigo carmine lake (E132)
.
500
Yellow iron oxide (E172)
.
750
Sunset yellow (E110)
,
Red iron oxide (E172)
.
:
250
:
,
,
,
.
500
:
,
,
,
.
750
:
,
,
,
.
1000
:
,
,
,
.
:
60
.
:
"
,
'
1
,
3060000
,
2023
.
:
250
:
149-63-33519-00
500
:
149-64-33518-00
750
: 149-65-33520-00
1000
:
149-66-33514-00
,
.
,
.
:
"
'
21
,
9548402
,